首页> 外文期刊>International journal of gynecological pathology: Official journal of the International Society of Gynecological Pathologists >p16INK4a Immunohistochemical and Histopathologic Study of Pap Test Cases Interpreted as HSIL Without CIN2-3 Identification in Subsequent Cervical Specimens
【24h】

p16INK4a Immunohistochemical and Histopathologic Study of Pap Test Cases Interpreted as HSIL Without CIN2-3 Identification in Subsequent Cervical Specimens

机译:p16INK4a子宫颈标本中不含CIN2-3鉴定为HSIL的巴氏试验病例的免疫组织化学和组织病理学研究

获取原文
获取原文并翻译 | 示例
           

摘要

Tissue biopsy following a pap test diagnosis of high grade squamous intraepithelial lesion (HSIL) sometimes fails to confirm the presence of a corresponding high grade cervical intraepithelial lesion (CIN 2-3), leading to confusion as to how best to manage the patient. It has been shown that these patients are still at higher risk for future detection of CIN 2-3 even if the initial biopsy fails to detect it. It has also been shown that immunohistochemical staining for p16INK4a can be reliably used as a surrogate marker for infection with high risk human papillomavirus in cervical samples, and that it can be used to enhance detection of CIN2-3 in cases where suspicion is high. To evaluate the use of p16INK4a staining in cases of HSIL which were not confirmed on initial biopsy, two pathologists rereviewed Pap and hematoxylin and eosin preparations from all such cases seen within the preceding 3 years. Immunohistochemical study for p16INK4a was performed and graded on representative sections. The results were tabulated and analyzed. Of the identified 596 HSIL Pap cases, 82% had HSIL on initial cervical specimens. Table 1 shows the 56 cases included in the study with graded and stratified p16INK4a results. On review of the p16INK4a slides, only 2 cases could be upgraded to HSIL/CIN2-3 from the original diagnosis. p16INK4a 2-3+ was expressed more frequently in cases initially interpreted on Pap as low-grade cervical lesion as compared with benign (24 of 35 cases). In the younger than 24-yr-old group p16 2-3+ reactivity was more frequent in benign and low-grade cervical lesion/CIN1 groups (benign: 3 of 5 cases, and CIN1: 6 of 8), and p16 negative reactivity was not seen. p16INK4a was graded 0-1+ more frequently in specimens interpreted as benign in the older than 25 yr olds (10 of 16 cases). The study suggests some diagnostic benefit from the use of p16INK4a immunohistochemical study on cervical specimens from women with a HSIL Pap test without HSIL/CIN2-3 on original hematoxylin and eosin review.
机译:通过巴氏试验诊断为高级别鳞状上皮内病变(HSIL)后的组织活检有时无法确认相应的高级别宫颈上皮内病变(CIN 2-3)的存在,导致在如何最好地管理患者方面产生了困惑。已经显示,即使最初的活检未能检测到这些患者,将来检测CIN 2-3的风险仍然较高。还已经显示,p16INK4a的免疫组织化学染色可以可靠地用作宫颈样品中高危人类乳头瘤病毒感染的替代标志物,并且在怀疑高度的情况下可以用于增强CIN2-3的检测。为了评估p16INK4a染色在初次活检时未证实的HSIL病例中的应用,两名病理学家对前三年内所有此类病例中的Pap,苏木精和曙红制剂进行了回顾。对p16INK4a进行了免疫组织化学研究,并在代表性部分进行了分级。将结果制成表格并进行分析。在确定的596例HSIL Pap病例中,有82%的初始宫颈标本上有HSIL。表1显示了该研究中包括的56例p16INK4a分级结果。回顾p16INK4a载玻片,仅2例可以从最初的诊断升级为HSIL / CIN2-3。与良性相比,最初在Pap上被解释为低度宫颈病变的病例中p16INK4a 2-3 +的表达更高(35例中有24例)。在年龄小于24岁的组中,p16 2-3 +反应在良性和低度宫颈病变/ CIN1组中更为常见(良性:5例中的3例,CIN1:8例中的6例),p16阴性没有被看到。在25岁以上的老年人(16例中有10例)被认为是良性的标本中,p16INK4a的评分更为频繁,为0-1 +。该研究表明,对原苏木精和曙红进行HSIL Pap试验且无HSIL / CIN2-3的女性宫颈标本使用p16INK4a免疫组织化学研究可带来一定的诊断价值。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号